Search results
Telix Files Registration Statement for Proposed Initial Public Offering in the United States
Benzinga· 7 hours agoTelix Pharmaceuticals Limited TLX Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States (U.S.) Securities ...
Moisture-induced power generator fabricated on a lateral field-excited quartz resonator - Scientific...
Nature· 6 days agoFigure 2a shows the molecular structures of SA and PVA, which are constituents of the SCP film. SA, which contains hydroxyl groups and sodium carboxylate groups (–COONa) in the polysaccharide ...
Atossa Therapeutics Inc (ATOS) Q1 2024 Earnings: Aligns with Analyst Projections Amidst ...
GuruFocus.com via Yahoo Finance· 4 days agoStrategic Outlook Atossa's CEO, Steven Quay, emphasized the strategic progress made in the quarter,...
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...
WKRN Nashville· 3 days agoNanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert ...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript May 8, 2024 Syndax...
What's Going On With Sidus Space Stock Tuesday? - Sidus Space (NASDAQ:SIDU)
Benzinga· 3 days agoSidus Space saw its shares rise following the successful completion of the commissioning phase for...
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
GuruFocus.com via Yahoo Finance· 7 days agoThese reductions contributed to the improved net loss figure. Selling, general, and administrative...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Lodi News-Sentinel· 3 days agoExpanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors
Atossa Therapeutics Inc (ATOS) Q1 2024 Earnings: Aligns with Ana
Guru Focus· 4 days agoOn May 13, 2024, Atossa Therapeutics Inc (ATOS, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The Seattle-based clinical-stage ...
Dividend Payouts Are Latest Sign of Big Tech’s Financial Muscle
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- After years of chasing growth at all costs, tech firms are taking a page from the...